Valve thrombosis following transcatheter aortic valve implantation: A systematic review;Revisión sistemática de la trombosis protésica tras implante percutáneo de válvula aórtica

Revista Espanola de Cardiologia

Volumn 68, Issue 3, 2015, Pages 198-204

  Córdoba Soriano, Juan G ^a   Puri, Rishi ^a   Amat Santos, Ignacio ^a   Ribeiro, Henrique B ^a   Abdul Jawad Altisent, Omar ^a   Del Trigo, María ^a   Paradis, Jean Michel ^a   Dumont, Eric ^a   Urena, Marina ^a   Rodés Cabau, Josep ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Aortic valve stenosis; Transcatheter aortic valve implantation; Valve thrombosis

Indexed keywords

ANTITHROMBOCYTIC AGENT; WARFARIN;

DYSPNEA; ECHOCARDIOGRAPHY; HUMAN; PROSTHETIC VALVE THROMBOSIS; REVIEW; SYSTEMATIC REVIEW; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; ADVERSE EFFECTS; AORTA VALVE; AORTIC VALVE STENOSIS; HEART DISEASES; POSTOPERATIVE COMPLICATION; THROMBOSIS;

AORTIC VALVE; AORTIC VALVE STENOSIS; HEART DISEASES; HUMANS; POSTOPERATIVE COMPLICATIONS; THROMBOSIS; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 84923568380     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2014.10.004     Document Type: Article

References (55)

1. J.C.J. Sun, M.J. Davidson, A. Lamy, and J.W. Eikelboom Antitrombotic management of patients with prosthetic heart valves: current evidence and future trends Lancet. 374 2009 565 576
2. K.E. Hammermeister, G.K. Sethi, W.G. Henderson, C. Oprian, T. Kim, and S. Rahimtoola A comparison of outcomes in men 11 years after heart-valve replacement with a mechanical valve or bioprosthesis N Engl J Med. 328 1993 1289 1296
3. M.L. Brown, S.J. Park, T.M. Sundt, and H.V. Schaff Early thrombosis risk in patients with biologic valves in the aortic position J Thorac Cardiovasc Surg. 144 2012 108 111
4. S.V. Pislaru, I. Hussain, P.A. Pellikka, J.J. Maleszewski, R.D. Hanna, and H.V. Schaff Misconceptions, diagnostic challenges and treatment opportunities in bioprosthetic valve thrombosis: lessons from a case series Eur J Cardiothorac Surg. 2014 Disponible en: http://dx.doi.org/10.1093/ejcts/ezu201
5. N. Dürrleman, M. Pellerin, D. Bouchard, Y. Hébert, R. Cartier, and L.P. Perrault Prosthetic valve thrombosis: twenty-year experience at the Montreal Heart Institute J Thorac Cardiovasc Surg. 127 2004 1388 1392
6. J. Rodes-Cabau Transcatheter aortic valve implantation: current and future approaches Nat Rev Cardiol. 9 2011 15 29
7. L. Nombela-Franco, J.G. Webb, P.P. De Jaegere, S. Toggweiler, R.G. Nuis, and A.E. Dager Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation Circulation. 126 2012 3041 3053
8. H. Eggebrecht, A. Schmermund, T. Voigtländer, P. Kahlert, R. Erbel, and R.H. Mehta Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients EuroIntervention. 8 2012 129 138
9. J.P. Fanning, D.L. Walters, D.G. Platts, E. Eeles, J. Bellapart, and J.F. Fraser Characterization of neurological injury in transcatheter aortic valve implantation. How clear is the picture? Circulation. 129 2014 504 515
10. T. Trepels, S. Martens, M. Doss, S. Fichtlscherer, and V. Schächinger Thrombotic restenosis after minimally invasive implantation of aortic valve stent Circulation. 120 2009 e23 e24
11. J. Kefer, P. Astarci, J. Renkin, D. Glineur, S. Pierard, and S. Seldrum Thrombotic aortic restenosis after transapical Sapien valve implantation Circ Cardiovasc Interv. 3 2010 289 292
12. E.L.W. Tay, R. Gurvitch, N. Wijeysinghe, F. Nietlispach, D. Wood, and M. Allard Valve thrombosis after transcatheter heart valve implantation EuroIntervention. 7 2011 170 171
13. A. Latib, D. Messika-Zeitoun, F. Maisano, D. Himbert, E. Agricola, and E. Brochet Reversible Edwards Sapien XT dysfunction due to prosthesis thrombosis presenting as early structural deterioration J Am Coll Cardiol. 19 2013 787 789
14. L. Cota, E. Stabile, M. Agrusta, G. Sorropago, A. Pucciarelli, and V. Ambrosini Bioprostheses "thrombosis" after transcatheter aortic valve replacement J Am Coll Cardiol. 19 2013 789 791
15. K.L. Greason, V. Mathew, M.E. Sarano, J.J. Maleszewski, R.M. Suri, and C.S. Rihal Early transcatheter aortic valve thrombosis J Card Surg. 28 2013 264 266
16. P. Lancelloti, M.A. Radermecker, S.H. Weisz, and V. Legrand Subacute transcatheter CoreValve thrombotic obstruction Circ Cardiovasc Interv. 6 2013 e32 e33
17. G. Pache, P. Blanke, W. Zeh, and N. Jander Cusp thrombosis after transcatheter aortic valve replacement detected by computed tomography and echocardiography Eur Heart J. 34 2013 3546
18. A. Orbach, B. Karkabi, and A. Shiran Reversible restenosis after transcatheter aortic valve implantation Eur Heart J Cardiovasc Imaging. 15 2014 350
19. A. Pergolini, P.G. Pino, G. Zampi, V. Polizzi, and F. Musumeci Thrombotic aortic restenosis after transapical SAPIEN valve implantation J Card Surg. 29 2014 204 208
20. S. Sanon, J.J. Maleszewski, and S.R. Charanjit Hydrophilic embolism induced acute transcatheter aortic valve thrombosis: a novel complication Catheter Cardiovasc Interven. 83 2014 1152 1155
21. F.S. De Brito Jr., A.M. Caixeta, M.L. Vieira, G. Nomura, G.L. Figueiredo, and M. Perin Pseudo early degeneration of a transcatheter aortic valve prosthesis due to thrombosis EuroIntervention. 2014 [Epub ahead of print]. pii: 20130812-04
22. T.H. Leetmaa, S.H. Poulsen, B.L. Norgaard, K.E. Klaaborg, K. Terp, and S. Hoyer Two cases of thrombotic stenosis in SAPIEN XT valves after transapical implantation EuroIntervention. 10 2014 270
23. M. Heras, J.H. Chesebro, V. Fuster, W.J. Penny, D.E. Grill, and K.R. Bailey High risk of thromboemboli early after bioprosthetic cardiac valve replacement J Am Coll Cardiol. 25 1995 1111 1119
24. M.I. Mydin, G. Dimitrakakis, J. Younis, J. Nowell, T. Athanasiou, and A. Korliouros Optimal thromboprophylaxis following bioprosthetic aortic valve replacement: still a matter of debate? Interact Cardiovasc Thorac Surg. 15 2012 109 114
25. J.P. Puvimanasinghe, E.W. Steyerberg, J.J. Takkenberg, C. Eijkemans, L.A. Van Herwerden, and A.J. Bogers Prognosis after aortic valve replacement with a bioprosthesis: predictions based on meta-analysis and microsimulation Circulation. 103 2001 1535 1541
26. K. Hammermeister, G.K. Sethi, W.G. Henderson, F.L. Grover, C. Oprian, and S.H. Rahimtoola Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial J Am Coll Cardiol. 36 2000 1152 1158
27. A. Cribier, H. Eltchaninoff, A. Bash, N. Borenstein, C. Tron, and F. Bauer Percutaneous transcatheter implantation of an aortic valve prosthesis for calcified aortic stenosis: first human case description Circulation. 106 2002 3006 3008
28. M.B. Leon, C.R. Smith, M. Mack, D.C. Miller, J.W. Moses, L.G. Svensson PARTNER Trial Investigators Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med. 363 2010 1597 1607
29. C.R. Smith, M.B. Leon, M.J. Mack, D.C. Miller, J.W. Moses, L.G. Svensson PARTNER Trial Investigators Transcatheter versus surgical aortic-valve replacement in high-risk patients N Engl J Med. 364 2011 2187 2198
30. T. Lefevre, A.P. Kappetein, E. Wolner, P. Nataf, M. Thomas, and V. Schächinger One year follow-up of the multi-centre European PARTNER transcatheter heart valve study Eur Heart J. 32 2011 148 157
31. J. Rodés-Cabau, J.G. Webb, A. Cheung, J. Ye, E. Dumont, and C.M. Feindel Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk acute and late outcomes of the multicenter Canadian experience J Am Coll Cardiol. 55 2010 1080 1090
32. M. Gilard, H. Eltchaninoff, B. Lung, P. Donzeau-Gouge, K. Chevreul, and J. Fajadet Registry of transcatheter aortic-valve implantation in high-risk patients N Engl J Med. 366 2012 1705 1715
33. H. Jilaihawi, T. Chakravarty, R.E. Weiss, G.P. Fontana, J. Forrester, and R.R. Makkar Meta-analysis of complications in aortic valve replacement: comparison of Medtronic-CoreValve, Edwards-Sapien and surgical aortic valve replacement in 8,536 patients Catheter Cardiovasc Interv. 80 2012 128 138
34. S.K. Kodali, M.R. Williams, C.R. Smith, L.G. Svensson, J.G. Webb, and R.R. Makkar Two-year outcomes after transcatheter or surgical aortic-valve replacement N Engl J Med. 366 2012 1686 1695
35. M. Thomas, G. Schymik, T. Walther, D. Himbert, T. Lefèvre, and H. Treede One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve Circulation. 124 2011 425 433
36. N.E. Moat, P. Ludman, M.A. De Belder, B. Bridgewater, A.D. Cunningham, and C.P. Young Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis. The U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry J Am Coll Cardiol. 58 2011 2130 2138
37. A. Linke, P. Wenaweser, U. Gerckens, C. Tamburino, J. Bosmans, and S. Bleiziffer Treatment of aortic stenosis with a self-expanding transcatheter valve: the International Multi-centre ADVANCE Study Eur Heart J. 35 2014 2672 2684
38. D.H. Adams, J. Popma, M.J. Reardon, S.J. Yakubov, J.S. Coselli, M. Deeb U.S. CoreValve Clinical Investigators Transcatheter aortic-valve replacement with a self-expanding prosthesis N Engl J Med. 370 2014 1790 1798
39. N. Jander, R.P. Kienzle, G. Kayser, F.J. Neumann, C. Gohlke-Baerwolf, and J. Minners Usefulness of phenprocoumon for the treatment of obstructing thrombus in bioprostheses in the aortic valve position Am J Cardiol. 109 2012 257 262
40. R.A. Nishimura, C.M. Otto, R.O. Bonow, E.A. Carabello, J.P. Erwin, R.A. Guyton ACC/AHA Task Force Members 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation. 129 2014 2440 2492
41. A. Vahanian, O. Alfieri, F. Andreotti, M.J. Antunes, G. Barón-Esquivias, and H. Baumgartner Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J. 33 2012 2451 2496
42. F.M. Cáceres-Loriga, H. Pérez-López, S. Santos-Gracia, and K. Morlans-Hernandez Prosthetic heart valve thrombosis: pathogenesis, diagnosis and management Int J Cardiol. 110 2006 1 6
43. A. Colli, J.P. Verhoye, R. Heijmen, J.T. Strauch, J.A. Hyde, and D. Pagano Antithrombotic therapy after bioprosthetic aortic valve replacement: ACTION Registry survey results Eur J Cardiothorac Surg. 33 2008 531 536
44. J.M. Brennan, K.P. Alexander, A. Wallace, A.B. Hodges, J.C. Laschinger, and K.W. Jones Patterns of anticoagulation following bioprosthetic valve implantation: observations from ANSWER J Heart Valve Dis. 21 2012 78 87
45. T.M. Sundt, K.J. Zehr, J.A. Dearani, R.C. Daly, C.J. Mullany, and C.G.A. McGregor Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement? J Thorac Cardiovasc Surg. 129 2005 1024 1031
46. R. Roudaut, K. Serri, and S. Lafitte Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations Heart. 93 2007 137 142
47. J.M. Brennan, F.H. Edwards, Y. Zhao, S. O'Brien, M.D. Booth, and R.S. Dokholyan Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database J Am Coll Cardiol. 60 2012 971 977
48. C. Merie, L. Kober, P. Skov Olsen, C.H. Andersson, G. Gislason, and J.S. Jensen Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding JAMA. 308 2012 2118 2125
49. J. Rodés-Cabau, H.L. Dauerman, M.G. Cohen, R. Mehran, E.M. Small, and S.S. Smyth Antithrombotic treatment in transcateheter aortic valve implantation. Insigths from cerebrovascular and bleeding events J Am Coll Cardiol. 62 2013 2349 2359
50. G. Huang, H.V. Schaff, T.M. Sundt, and S.H. Rahimtoola Treatment of obtructive thrombosed prostetic heart valve J Am Coll Cardiol. 62 2013 1731 1736
51. A. Butnaru, J. Shaheen, D. Tzivoni, R. Tauber, D. Bitran, and S. Silberman Diagnosis and treatment of early bioprosthetic malfunction in the mitral valve position due to thrombus formation Am J Cardiol. 112 2013 1439 1444
52. H. Mohammadi, and K. Mequanint Prosthetic aortic heart valves: modeling and design Med Eng Phys. 33 2011 131 147
53. E.L. Tay, R. Gurvitch, N. Wijesinghe, F. Nielispach, D. Wood, and A. Cheung A high-risk period for cerebrovascular events exists after transcatheter aortic valve implantation JACC Cardiovasc Interv. 4 2011 1290 1297
54. A. Linke, R. Höllriegel, T. Walther, K. Schierle, C. Wittekind, and J. Ender Ingrowths of a percutaneously implanted aortic valve prosthesis (CoreValve) in a patient with severe aortic stenosis Circ Cardiovasc Interv. 1 2008 155 158
55. A. Ducci, S. Tzamtzis, M.J. Mullen, and G. Burriesci Hemodynamics in the Valsalva sinuses after transcatheter aortic valve implantation (TAVI) J Heart Valve Dis. 22 2013 688 696